In contrast to KRAS-altered non-Sq NSCLC, EGFR-altered tumors appeared to have a more conserved co-occurrence and mutual exclusivity alteration landscape across ancestry groups (Figs. 2c, 3c, Supplementary Data 5, Supplementary Data 11). This evidence concerns the gene KRAS and non-small cell lung carcinoma.